Grasso S, Chimirri A, Monforte P, Fenech G
Farmaco Sci. 1984 Jun;39(6):505-13.
2-Substituted 3-(2-thiazolyl) and 3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones were prepared and tested for their activity against the leukemic P 388 tumor system in mice. The thiadiazolyl derivatives are generally more active than the thiazolyl ones and some of them showed significant activity.
制备了2-取代的3-(2-噻唑基)和3-[2-(1,3,4-噻二唑基)]-4-噻唑烷酮,并对其在小鼠白血病P 388肿瘤系统中的活性进行了测试。噻二唑基衍生物通常比噻唑基衍生物更具活性,其中一些表现出显著活性。